The European Central Bank may no longer mention the need to adopt a "restrictive" policy to curb inflation. The financial market has completely digested the expectation that the European Central Bank will cut interest rates by 25 basis points on Thursday, and the possibility of a larger rate cut is close to zero. Any adjustment of the ECB's future guidance may be minimal. It may no longer mention the need to adopt "restrictive" policies to curb inflation, which is an implicit signal that interest rates will at least fall to the so-called neutral level. Lorenzo Codogno of LC Macro Advisors said: "In view of the great uncertainties in international geopolitics and policies, it is still appropriate to rely on data and determine the appropriate level and duration of restrictions one after another."Musk: Nothing is more beneficial to American health than "ultra-low-cost" diet pills. Musk advocates the use of diet pills to reduce American medical expenses. On December 11th, local time, Musk posted on social platform X that nothing can improve the health, longevity and quality of life of Americans better than very cheap GLP-1 drugs. He pointed out that most medical expenses occur at the end of life, and obesity is often an important factor leading to diseases. Therefore, popularizing GLP-1 drugs can save medical expenses on a long-term scale.Game stocks fluctuated, raising the daily limit of Xinghui Entertainment, Xinghui Entertainment, Fuchun Shares, Youzu Network, day boat culture, Tomcat and Zhongqingbao.
The Australian dollar's yield on Australian bonds rose. The Australian employment data was better than expected, and the Australian dollar's gains expanded. The previously released data showed that the unemployment rate in Australia unexpectedly fell last month, which cooled the speculation surrounding the Australian central bank's interest rate cut. AUD/USD rose 0.7% to 0.6412; Report 0.6378 before data release. The yield of 3-year Australian government bonds rose from 3.75% before the data was released to 3.79%.The Supreme People's Procuratorate decided to arrest Liu Xingtai in accordance with the law. It was learned from the Supreme People's Procuratorate that Liu Xingtai, the former deputy secretary and deputy director of the Standing Committee of Hainan Provincial People's Congress, was suspected of taking bribes, which was investigated by the National Supervisory Commission (NSC) and transferred to the procuratorate for review and prosecution. A few days ago, the Supreme People's Procuratorate made a decision to arrest Liu Xingtai on suspicion of accepting bribes. The case is being further processed. (CCTV News)Russia said it would not make concessions on the Ukrainian issue and hoped to make contact with the US. Russian Foreign Ministry spokesman Zacharova said at a regular press conference on the 11th local time that Russia would not make concessions on the Ukrainian issue in response to the negotiation proposal put forward by US President-elect Trump on the 8th, and hoped to make contact with the US, but so far it has not received any "serious suggestions" from the team of US President-elect Trump. Zacharova also said that the recent statement of Ukrainian President Zelensky showed that "achieving peace is not a priority for Ukraine". Zelensky reiterated a few days ago that Uzbekistan will not sign any kind of peace agreement without security guarantee.
Treasury futures collectively opened higher, with 30-year main contracts up 0.21%, 30-year main contracts up 0.21%, 10-year main contracts up 0.09%, 5-year main contracts up 0.03% and 2-year main contracts up 0.01%.The pharmaceutical business sector rose short-term, and the pharmaceutical business sector rose short-term. The pharmaceutical business sector rose short-term, and the pharmaceutical business sector rose short-term. Seli Medical, Chinese Health, Pharmaceuticals Tesco, Shuyu Civilians and Neptune Biology followed suit.The net outflow of the main market exceeded 10 billion.
Strategy guide
Strategy guide
Strategy guide
12-13
Strategy guide
12-13
Strategy guide
12-13
Strategy guide 12-13
Strategy guide
12-13